Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $42,668 | 15 | 50.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,445 | 9 | 21.8% |
| Consulting Fee | $10,603 | 36 | 12.5% |
| Travel and Lodging | $8,137 | 78 | 9.6% |
| Food and Beverage | $4,735 | 133 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $61,402 | 176 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $12,463 | 23 | $0 (2021) |
| PFIZER INC. | $8,625 | 11 | $0 (2024) |
| ABBVIE INC. | $773.34 | 38 | $0 (2024) |
| NuVasive, Inc. | $481.29 | 4 | $0 (2022) |
| IMPEL PHARMACEUTICALS INC. | $204.52 | 3 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $192.99 | 4 | $0 (2022) |
| TONIX PHARMACEUTICALS, INC. | $180.65 | 1 | $0 (2023) |
| Amgen Inc. | $78.85 | 1 | $0 (2019) |
| Genentech USA, Inc. | $36.63 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,316 | 76 | Lundbeck LLC ($21,558) |
| 2023 | $23,627 | 76 | Lundbeck LLC ($23,261) |
| 2022 | $17,762 | 83 | Lundbeck LLC ($16,582) |
| 2021 | $12,707 | 29 | Biohaven Pharmaceuticals, Inc. ($12,463) |
| 2019 | $105.01 | 2 | Amgen Inc. ($78.85) |
| 2018 | $56.68 | 4 | GENZYME CORPORATION ($34.72) |
| 2017 | $14.67 | 1 | Genentech USA, Inc. ($14.67) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $31.88 | General |
| Category: Vascular | ||||||
| 12/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $241.40 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $79.96 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | PFIZER INC. | ZAVZPRET (Drug) | Travel and Lodging | In-kind items and services | $321.60 | General |
| Category: PAIN | ||||||
| 12/04/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $38.18 | General |
| Category: PAIN | ||||||
| 12/04/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: PAIN | ||||||
| 12/04/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: PAIN | ||||||
| 11/23/2024 | PFIZER INC. | ZAVZPRET (Drug) | Travel and Lodging | In-kind items and services | $153.44 | General |
| Category: PAIN | ||||||
| 11/22/2024 | PFIZER INC. | ZAVZPRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,125.00 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $123.84 | General |
| Category: PAIN | ||||||
| 11/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $46.67 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $84.82 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $3,255.00 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $110.14 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $22.94 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $19.98 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $17.38 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $12.65 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $8.60 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $7.91 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $5.00 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $5.00 | General |
| Category: NEUROLOGY | ||||||
| 10/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $238.26 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 171 | 234 | $71,082 | $17,027 |
| 2022 | 5 | 123 | 182 | $58,594 | $14,878 |
| 2021 | 5 | 143 | 216 | $64,661 | $17,509 |
| 2020 | 2 | 22 | 23 | $6,351 | $1,664 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 65 | $24,410 | $6,744 | 27.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 20 | 37 | $13,947 | $3,194 | 22.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $10,504 | $2,102 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 28 | $7,450 | $2,088 | 28.0% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Facility | 2023 | 18 | 32 | $12,161 | $1,742 | 14.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 25 | 36 | $2,016 | $764.80 | 37.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 15 | 18 | $594.00 | $392.66 | 66.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 51 | 74 | $26,872 | $7,283 | 27.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 14 | 39 | $14,184 | $3,125 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 28 | 33 | $8,592 | $2,175 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $7,772 | $1,831 | 23.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 16 | 22 | $1,174 | $464.17 | 39.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 56 | 85 | $29,215 | $8,782 | 30.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 24 | 24 | $12,600 | $3,378 | 26.8% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 17 | 37 | $12,580 | $3,239 | 25.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 32 | 50 | $2,500 | $1,129 | 45.2% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Facility | 2021 | 14 | 20 | $7,766 | $980.89 | 12.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 11 | 12 | $3,988 | $953.70 | 23.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $2,363 | $710.79 | 30.1% |
About Dr. Michael Yang, MD
Dr. Michael Yang, MD is a Neurology healthcare provider based in La Crosse, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1265826762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Yang, MD has received a total of $84,588 in payments from pharmaceutical and medical device companies, with $30,316 received in 2024. These payments were reported across 271 transactions from 15 companies. The most common payment nature is "Honoraria" ($42,668).
As a Medicare-enrolled provider, Yang has provided services to 459 Medicare beneficiaries, totaling 655 services with total Medicare billing of $51,080. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location La Crosse, WI
- Active Since 03/23/2015
- Last Updated 09/01/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1265826762
Products in Payments
- VYEPTI (Biological) $61,402
- NURTEC ODT (Drug) $14,958
- ZAVZPRET (Drug) $6,322
- QULIPTA (Drug) $504.07
- RELINE (Device) $247.72
- Trudhesa (Drug) $204.52
- UBRELVY (Drug) $191.02
- ZEMBRACE SYMTOUCH (Drug) $180.65
- Pulse (Device) $95.82
- Aimovig (Biological) $78.85
- OCREVUS (Biological) $36.63
- BOTOX (Biological) $36.40
- NAVITOR (Device) $31.88
- EMGALITY (Drug) $28.24
- SOLIRIS (Drug) $26.16
- POMPE - DISEASE (Drug) $20.21
- AJOVY (Biological) $16.24
- FABRY-DISEASE (Drug) $14.51
- AUSTEDO (Drug) $13.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in La Crosse
Mr. Paul Spanel, D.o, D.O
Neurology — Payments: $23,241
Dr. Rachel Biemiller, Md, MD
Neurology — Payments: $8,736
Michael Doerrler, D.o, D.O
Neurology — Payments: $8,668
Mr. Smathorn Thakolwiboon, Md, MD
Neurology — Payments: $2,683
Ragasri Kumar Merkes, D.o, D.O
Neurology — Payments: $2,256
Evan Sandok, Md, MD
Neurology — Payments: $1,973